JBIO
Jade Biosciences, Inc.
14.70$
-12.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -9.6% | -16.2% | +4.6% | -18.6% | -11.7% | -3.5% | +188.9% | -9.6% | +72.8% | -8.7% | +47.8% | |
| – | -9.7% | -16.9% | +7.3% | -18.2% | -11.6% | -3.4% | +188.2% | -9.7% | +66.9% | -5.2% | +48.0% | |
| – | -27.0% | -61.2% | +240.6% | +0.1% | +8.5% | +31.0% | +399.6% | -77.3% | +76.5% | -37.7% | +94.7% | |
| – | -9.4% | -18.9% | +4.9% | -14.8% | -11.4% | -3.1% | +189.9% | -10.0% | +69.0% | -7.4% | +48.2% | |
| – | +18.5% | -11.4% | +8.7% | -39.5% | -62.8% | -36.2% | +801.2% | +3.1% | -25.3% | +33.1% | +40.2% | |
| – | +19.8% | -12.0% | +9.7% | -39.4% | -62.9% | -36.9% | +794.5% | +3.4% | -26.0% | +34.8% | +41.6% | |
| – | -6.9% | +6.0% | +6.7% | -3.4% | -9.2% | -25.2% | – | – | – | – | – | |
| – | -31.6% | +38.3% | +26.1% | -78.3% | -75.3% | -69.2% | +10,894.2% | -82.2% | +59.3% | +85.0% | +65.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -12.9% | -16.9% | +3.8% | -14.7% | -5.0% | -1.8% | +168.6% | -11.0% | +85.4% | -10.8% | +48.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +0.4% | +3.5% | +284.1% | -73.8% | +0.0% | +3,333.1% | +39.2% | +24.6% | +17.2% | +5.7% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.